Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reactions
Clinical Data From the Pivotal Penumbra Stroke Trial Presented at the International Stroke Conference's Late Breaking Science Session
March 16th, 2008
Clinical results from the pivotal trial of the Penumbra System were presented today at the 2008 ASA International Stroke Conference in New Orleans by Dr. Cameron McDougall, Chief of Endovascular Neurosurgery at Barrow Neurological Institute, on behalf of the Penumbra Stroke Trial investigators. The Penumbra Stroke Trial is a prospective, single arm, multi-center trial that enrolled 125 patients at 24 international centers. Patients in the trial presented within 8 hours from symptom onset, had an NIH Stroke Scale (NIHSS) score of greater than or equal to 8, and a complete occlusion of a large intracranial vessel. In December 2007, based on the results of this pivotal...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-16)
|
